Overview
Kenneth Rosenbaum is a Medical Genetics specialist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Rosenbaum is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. His top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Triple X Syndrome, and Williams Syndrome. Dr. Rosenbaum is currently accepting new patients.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins. Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy. Contact for Research Inquiries 600 N. Wolfe Street Meyer 2-147 Baltimore, MD 21287 Phone: (410) 955-9100. Dr. Habela is rated as a Distinguished provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Epilepsy, and Endovascular Embolization.
Akua Asiedu is a Pediatrics provider in Washington, Washington, D.c.. Dr. Asiedu is rated as an Experienced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Autism Spectrum Disorder, 15q11.2 Microdeletion, Jacobsen Syndrome, and Distal 18q Deletion Syndrome.
University Of Maryland Pediatric Associates, PA
Sofia Saenz-Ayala is a Medical Genetics specialist and a Pediatrics provider in Baltimore, Maryland. Dr. Saenz-Ayala is rated as an Advanced provider by MediFind in the treatment of 15q11.2 Microdeletion. Her top areas of expertise are Musculocontractural Ehlers-Danlos Syndrome (mcEDS), Ehlers-Danlos Syndrome (EDS), Carnitine Palmitoyltransferase 1 Deficiency, and Carnitine Palmitoyltransferase 2 Deficiency. Dr. Saenz-Ayala is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- NeurofibromatosisDr. Rosenbaum isAdvanced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Rosenbaum isAdvanced. Learn about Neurofibromatosis Type 1 (NF1).
- Triple X SyndromeDr. Rosenbaum isAdvanced. Learn about Triple X Syndrome.
- Experienced
- 15q11.2 MicrodeletionDr. Rosenbaum isExperienced. Learn about 15q11.2 Microdeletion.
- 2q37 Deletion SyndromeDr. Rosenbaum isExperienced. Learn about 2q37 Deletion Syndrome.
- 3MC SyndromeDr. Rosenbaum isExperienced. Learn about 3MC Syndrome.
- 3p Deletion SyndromeDr. Rosenbaum isExperienced. Learn about 3p Deletion Syndrome.
- 47 XYY SyndromeDr. Rosenbaum isExperienced. Learn about 47 XYY Syndrome.
- Aarskog SyndromeDr. Rosenbaum isExperienced. Learn about Aarskog Syndrome.
